专利检索 ap:("ELANCO Tiergesundheit AG") AND inv:"Noelle Gauvry" 第 1 页

1.

发明授权
Compounds 有权

公开(公告)号：US10059709B2

公开(公告)日：2018-08-28

申请号：US15119800

申请日：2015-03-25

申请人： Elanco Tiergesundheit AG

发明人： Noelle Gauvry , Chouaib Tahtaoui , Pascal Furet , Pierre Ducray

IPC分类号： C07D471/14 , C07D239/46 , C07D471/04 , A61K31/44 , C07D473/34 , C07D487/04 , C07D495/04 , C07D239/42 , C07D239/48

CPC分类号： C07D471/14 , C07D239/42 , C07D239/46 , C07D239/48 , C07D471/04 , C07D473/34 , C07D487/04 , C07D495/04

摘要： The invention relates to a compound of formula (I) wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful as therapeutic agent for organ transplants, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes and complications from diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, inflammatory bowel diseases, Crohn's disease, Alzheimer's disease, leukemia, osteoarthritis, control of pruritus, chronic respiratory disease or keratoconjunctivitis in mammals.

2.

发明授权
Sulfonylaminobenzamide compounds as anthelmintics 有权

公开(公告)号：US10047040B2

公开(公告)日：2018-08-14

申请号：US15502512

申请日：2015-08-27

申请人： Elanco Tiergesundheit AG

发明人： Noelle Gauvry , Chouaib Tahtaoui

IPC分类号： C07C311/08 , C07F7/08 , C07F5/02 , C07D295/155 , C07D333/24 , C07D231/12 , C07D213/61 , C07D231/56 , C07D213/56 , C07D239/30 , C07D239/26 , C07D277/30 , C07D213/84 , C07D333/28 , C07C311/21 , C07C311/14 , C07D309/06 , C07D249/08 , C07D277/64 , C07D277/60 , C07D277/56 , C07D285/135 , C07D333/78 , C07D277/46 , C07D277/54 , C07D263/50 , C07D275/03 , C07D317/66 , C07D209/08 , C07D215/06 , C07D487/04 , C07D237/26

CPC分类号： C07C311/08 , C07C235/56 , C07C307/10 , C07C311/09 , C07C311/10 , C07C311/14 , C07C311/21 , C07C311/29 , C07C2601/02 , C07C2601/14 , C07C2602/08 , C07C2602/40 , C07C2602/42 , C07D209/08 , C07D213/26 , C07D213/56 , C07D213/61 , C07D213/64 , C07D213/65 , C07D213/84 , C07D215/06 , C07D231/12 , C07D231/20 , C07D231/56 , C07D237/26 , C07D239/26 , C07D239/30 , C07D239/34 , C07D249/08 , C07D249/12 , C07D263/50 , C07D275/03 , C07D277/30 , C07D277/46 , C07D277/54 , C07D277/56 , C07D277/60 , C07D277/62 , C07D277/64 , C07D279/12 , C07D285/135 , C07D295/155 , C07D295/185 , C07D295/26 , C07D309/06 , C07D317/66 , C07D333/24 , C07D333/28 , C07D333/78 , C07D487/04 , C07F5/025 , C07F7/081 , C07F7/0812

摘要： The present invention relates to a new compound of formula (I) wherein the variables have the meaning as indicated in the claims; or an enantiomer or salt thereof. The compounds of formula (I) are useful in the control of parasites, in particular endoparasites, in and on vertebrates.

3.

发明授权
Sulfonylaminobenzamide compounds as anthelmintics 有权

公开(公告)号：US10464889B2

公开(公告)日：2019-11-05

申请号：US16037396

申请日：2018-07-17

申请人： ELANCO Tiergesundheit AG

发明人： Noelle Gauvry , Chouaib Tahtaoui

IPC分类号： C07C311/08 , C07D277/62 , C07D213/61 , C07D213/84 , C07D231/12 , C07D231/20 , C07D231/56 , C07C307/10 , C07D333/24 , C07D333/28 , C07C311/10 , C07C311/14 , C07C311/21 , C07C311/29 , C07D239/26 , C07D239/30 , C07D239/34 , C07D249/12 , C07D277/30 , C07D277/64 , C07D279/12 , C07D295/155 , C07D295/185 , C07D295/26 , C07D213/26 , C07D213/64 , C07D213/65 , C07C311/09 , C07C235/56 , C07F5/02 , C07F7/08 , C07D209/08 , C07D213/56 , C07D215/06 , C07D237/26 , C07D249/08 , C07D263/50 , C07D275/03 , C07D277/46 , C07D277/54 , C07D277/56 , C07D277/60 , C07D285/135 , C07D309/06 , C07D317/66 , C07D333/78 , C07D487/04

摘要： The present invention relates to a new compound of formula (I) wherein the variables have the meaning as indicated in the claims; or an enantiomer or salt thereof. The compounds of formula (I) are useful in the control of parasites, in particular endoparasites, in and on vertebrates.

4.

发明授权
Heterocyclyl-substituted cyclohexylsulfonamides as JAK inhibitors 有权

公开(公告)号：US10370375B2

公开(公告)日：2019-08-06

申请号：US16055560

申请日：2018-08-06

申请人： Elanco Tiergesundheit AG

发明人： Noelle Gauvry , Chouaib Tahtaoui , Pascal Furet , Pierre Ducray

IPC分类号： C07D471/14 , C07D239/46 , C07D471/04 , C07D473/34 , C07D487/04 , C07D495/04 , C07D239/42 , C07D239/48

摘要： The invention relates to a compound of formula (I) wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful as therapeutic agent for organ transplants, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis. Type I diabetes and complications from diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, inflammatory bowel diseases, Crohn's disease, Alzheimer's disease, leukemia, osteoarthritis, control of pruritus, chronic respiratory disease or keratoconjunctivitis in mammals.

5.

发明申请
New Compounds 审中-公开

公开(公告)号：US20180346465A1

公开(公告)日：2018-12-06

申请号：US16055560

申请日：2018-08-06

申请人： Elanco Tiergesundheit AG

发明人： Noelle Gauvry , Chouaib Tahtaoui , Pascal Furet , Pierre Ducray

IPC分类号： C07D471/14 , C07D239/48 , C07D471/04 , C07D473/34 , C07D487/04 , C07D495/04 , C07D239/42 , C07D239/46

CPC分类号： C07D471/14 , C07D239/42 , C07D239/46 , C07D239/48 , C07D471/04 , C07D473/34 , C07D487/04 , C07D495/04

摘要： The invention relates to a compound of formula (I) wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful as therapeutic agent for organ transplants, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis. Type I diabetes and complications from diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, inflammatory bowel diseases, Crohn's disease, Alzheimer's disease, leukemia, osteoarthritis, control of pruritus, chronic respiratory disease or keratoconjunctivitis in mammals.